close

Login

Library
Shopping Cart
Remember Me
Forgot password/Login issues?
loading animation for AJAX calls
 
 
Direct (781) 489-7301,  Toll Free (866) 285-7215

Search

Search
BCC Advance Search

Choose your License

loading animation for AJAX calls

Global Markets for Vaccine Technologies

REPORT HIGHLIGHTS

Global revenue for vaccine technologies was nearly $31.8 billion in 2011. This market is expected to increase from $33.6 billion in 2012 to $43.4 billion in 2017 at a compound annual growth rate (CAGR) of 5.3%.

This report provides:

  • An overview of the global market for human and animal (veterinary) vaccines and related vaccine technologies.
  • Analyses of global market trends, with data from 2010, 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017.
  • Examination of current and future strategies within the human and animal (veterinary) vaccines markets, including attenuated (live) vaccines, inactivated (killed) vaccines, conjugate vaccines, recombinant/recombinant DNA (rDNA) vaccines, subunit vaccines, toxoid vaccines, and combination vaccines.
  • A breakdown of the seven major categories of vaccines broken down by market shares belonging to leading manufacturers and/or suppliers.
  • Discussion of human and animal (veterinary) vaccines as to their prophylactic or therapeutic use, with emphasis in the meningococcal/pneumococcal vaccines, influenza vaccines, pediatric vaccines, adult/adolescent vaccines, and travel vaccines.

SAMPLE FIGURE
GLOBAL SALES OF HUMAN AND ANIMAL VACCINES, 2010-2017
($ MILLIONS)
GLOBAL SALES OF HUMAN AND ANIMAL VACCINES, 2010-2017
To Contact us, click here  help


Source: BCC Research

REPORT SCOPE

INTRODUCTION

STUDY OBJECTIVES

This BCC study assesses and analyzes advancements in the human and animal vaccine industry. The report discusses the current dynamics of the vaccine market and predicts the future market growth based on factors such as current products, trends in the strategic moves of multinational companies, market share, product pipelines, consumer behavior and the immunization strategies of various governmental and non-governmental organizations. This study also examines the key aspect of health safety for both human and animal vaccination programs.

The report presents the present market and its potential for growth, including revenue estimations, product types/categories, market leaders, market shares and factors and drivers influencing the market for human and animal vaccines. In addition, the report summarizes the scientific platforms, innovations, top-selling products and prospective candidates for the present and future market. Vaccine market trends, coverage plans by key vaccine regulatory bodies, patents and health safety concerns are also presented in the report. The opportunities and challenges presented to vaccine manufacturers and government bodies, especially in the developing countries, are discussed within this report.

The report presents the sales data of vaccine manufacturing companies and other relevant sources where available. The vaccine market is analyzed by types or categories for human and animal vaccines for the period of 2010 to 2012. In addition, revenue projections are given for 2017. The report also presents data on regional sales of vaccines in North America (the U.S. and Canada), Europe and the emerging markets.

REASONS FOR DOING THIS STUDY

The progress in the vaccine industry from the perspective of usage, coverage, awareness and innovation over the past decade has been noteworthy. The study covers the latest industry developments for human and animal vaccines, including updates on financial, scientific, research and new product developments. Human vaccines offer a solution to improving health worldwide. The report offers companies an analysis that they can use in strategizing their immunization plans going forward.

The latest market trends, including mergers/joint ventures, market penetration of large companies in the ever-growing developing markets, research, changing consumer preferences, health and safety awareness and immunization coverage campaigns are driving the vaccine market. These trends are opening up diverse opportunities for manufacturers and scientists to develop innovative and affordable products. This study summarizes these factors for both the human and animal vaccine industries.

CONTRIBUTIONS OF THE STUDY AND FOR WHOM

This study emphasizes the necessity of vaccines in ensuring the health of both humans and animals. For human vaccines, the focus is on the developing countries where access to vaccines is badly needed. For animals, vaccination is a health safety requirement to ensure the health of animals and to avoid the transference of diseases from animals to humans, for both food producing animals and companion animals. The study offers an overview of the vaccine industry for market participants such as manufacturers, researchers and non-governmental organizations.

SCOPE OF THE STUDY

The report studies the various factors impacting the global market for human and animal vaccines. BCC conducted a market evaluation for vaccine types/categories for humans and animals, including their respective regional sales, applications, regulatory aspects, market forecasts, prospects, innovation and challenges, patent analyses, clinical trials, market leaders and market shares of vaccine sales.

The data gathered is for the global markets and statistically validated for the current and forecasted values. Similar techniques were applied for regional data measurements and sales in the respective regions studied. Product details and scientific techniques/platforms are provided based on their commercial and industrial viability.

The emerging markets for orphan drugs include India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand.

METHODOLOGY

BCC employed both primary as well as secondary research methodologies to gather relevant information on the vaccine industry. In order to do that, BCC interviewed industry veterans, including scientists, manufacturers and others as well as conducted relevant searches, including pharmaceutical and vaccine related newsletters, blogs, papers, journals, technical blogs, digests, news feeds, technical articles, company white papers, research papers and other sources. Market projections reflect estimated unit prices, vaccine usage and potential immunization coverage, the present market economy, future application of vaccines and market direction and trends.

INFORMATION SOURCES

BCC researched companies associated with the vaccine industry to acquire data for this study. These companies were mostly manufacturers and end users of vaccines for both humans and animals. BCC contacted industry representatives of vaccine companies, scientists and research teams to gain better insight into the prospects and development of the industry.

In addition, BCC consulted scientific papers, research papers and articles, science journal, medical and pharmaceutical papers and journals, company white papers, financial reports, newsletters, company literature, medical and pharmaceutical blogs, product literature, technical articles, periodicals, bulletins, abstracts, regulations, patent files, etc. Pharmaceutical and medical related database searches were also key contributors for the research work.

ABOUT THE AUTHOR

The study has been carried out by a team of professionals engaged in the biotechnology industry. The project manager of this study is Shalini S. Dewan, who holds a master’s degree in pharmaceutical chemistry and has more than 14 years of industry experience. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC include: Reagents for Chromatography; Spectroscopy: An Enduring Market; Advanced Drug Delivery Systems: Technologies and Global Markets; Orthopedic Drugs, Implants and Devices; Medical Imaging Reagents and Analysis Equipment; Pharmaceutical Regulatory Industry; The Dynamic Media, Sera and Reagent Market in Biotechnology; Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets; Chiral Technology: Global Markets; Autacoids and Related Drugs: Technologies and Global Markets; Contraceptives: Technologies and Global Markets; Liver Disease Treatments: The Global Market; Hormone Replacement Therapies and Other Hormone Therapies: Global Markets; Cardiovascular Medicine: Diagnostics, Drugs and Devices; and Cancer Therapies: Technologies and Global Markets.

The lead consultant on this project was Ms. Ruma Chakravarty, who holds a master’s degree in biophysics. She has tremendous experience in market research, quality, process improvement and lean and six sigma concepts.

BCC ONLINE SERVICES

BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:

  • Examine BCC’s complete catalog of Market Research Reports and place direct orders.
  • Subscribe to any of BCC’s many industry newsletters.
  • Read announcements of recently published reports and newly launched newsletters.
  • Register for BCC’s well-known conferences.
  • Request additional information on any BCC product.
  • Take advantage of special offers.

DISCLAIMER

The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal or accounting advice; nor should it serve as a corporate policy guide, laboratory manual or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or from its use.

REPORT TOC

Pricing on the website is provided for single users and 2-5 users licenses only. Please contact us at (+1)781-489-7301 or send an email to help@bccresearch.com to purchase multi-user licenses.
  Title/Chapter Name Pages Price
Global Markets for Vaccine Technologies 272 $6650
Chapter- 1: INTRODUCTION - Complimentary 4 $0
  Show Details
Chapter- 2: EXECUTIVE SUMMARY 3 $250
  Show Details
Chapter- 3: OVERVIEW 32 $1174
  Show Details
Chapter- 4: REGULATORY ASPECTS 11 $403
  Show Details
Chapter- 5: PREVALENCE 6 $220
  Show Details
Chapter- 6: NEW DEVELOPMENTS 11 $403
  Show Details
Chapter- 7: GLOBAL MARKETS FOR HUMAN AND ANIMAL VACCINES 23 $843
  Show Details
Chapter- 8: MARKET ANALYSIS OF HUMAN VACCINES 60 $2200
  Show Details
Chapter- 9: MARKET ANALYSIS OF ANIMAL VACCINES 21 $770
  Show Details
Chapter- 10: PATENT ANALYSIS 37 $1357
  Show Details
Chapter- 11: CURRENT SITUATION 18 $660
  Show Details
Chapter- 12: COMPANY PROFILES 44 $1614
  Show Details
Chapter- 13: APPENDIX I 2 $73
  Show Details
 
  List of Tables
  List of Figures
 
  • Purchase Report
  • Download Table of Contents
  • Contact Us